Evidence map›Paper›PMID 27817099›Full record

ArticleMycotoxin research2017

Deoxynivalenol and its metabolite deepoxy-deoxynivalenol: multi-parameter analysis for the evaluation of cytotoxicity and cellular effects.

Alexandra Springler, Sabine Hessenberger, Nicole Reisinger, Corinna Kern, Veronika Nagl, Gerd Schatzmayr, Elisabeth Mayer

Open access · hybridAbstract read
In one paragraph

Article in Mycotoxin research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
11.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recent Research onFoods (Basel, Switzerland) · 2022
    Review
  9. Article
  10. 3-keto-DON, but Not 3-International journal of molecular sciences · 2022
    Article
  11. Article
  12. Cellular Apoptosis Induced by Deoxynivalenol.Indian journal of microbiology · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Biodegradation of Deoxynivalenol byFrontiers in microbiology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexandra SpringlerBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Sabine HessenbergerBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Nicole ReisingerBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Corinna KernBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Veronika NaglBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Gerd SchatzmayrBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria.
Elisabeth MayerBIOMIN Research Center, Technopark 1, 3430, Tulln an der Donau, Austria. e.mayer@biomin.net.ORCID http://orcid.org/0000-0002-2051-272X
Austrian Institute of Technology · ATBOKU University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mycotoxin deoxynivalenol (DON) contaminates agricultural commodities worldwide, posing health threats to humans and animals. Associated with DON are derivatives, such as deepoxy-deoxynivalenol (DOM-1), produced by enzymatic transformation of certain intestinal bacteria, which are naturally occurring or applied as feed additives. Using differentiated porcine intestinal epithelial cells (IPEC-J2), we provide the first multi-parameter comparative cytotoxicity analysis of DON and DOM-1, based on the parallel evaluation of lysosomal activity, total protein content, membrane integrity, mitochondrial metabolism and ATP synthesis. The study investigated the ability of DON and-for the first time of its metabolite DOM-1-to induce apoptosis, mitogen-activated protein kinase (MAPK) signalling, oxidative events and alterations of mitochondrial structure in porcine intestinal epithelial cells (IECs). The degree of DON toxicity strongly varied, depending on the cytotoxicity parameter evaluated. DON compromised viability according to the parameters of lysosomal activity, total protein content and membrane integrity, but increased viability according to assays based on mitochondrial metabolism and ATP synthesis. DON induced expression of cleaved caspase-3 (maximum induction 3.9-fold) and MAPK p38 and p42/p44 (maximum induction 2.51- and 2.30-fold, respectively). DON altered mitochondrial morphology, but did not increase intracellular ROS. DOM-1-treated IPEC-J2 remained unaffected at equimolar concentrations in all assays, thereby confirming the safety of feed additives using DON- to DOM-1-transforming bacteria. The study additionally highlights that an extensive multi-parameter analysis significantly contributes to the quality of in vitro data.

Indexed as

AnimalsApoptosisCell LineEpithelial CellsMitochondriaMycotoxinsOxidative StressSignal TransductionSwineTrichothecenesdeepoxy-deoxynivalenoldeoxynivalenolMycotoxinsTrichothecenesApoptosisIn vitroIPEC-J2MAPK signallingMitochondriaMycotoxin

Identifiers

PMID27817099
PMCPMC5239812
OpenAlexW2546888171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.